Trial site
Azienda Ospedaliero Universitaria Consorziale Policlinico Di Bari
- 19running trials
- 7closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia2 trials
- Childhood cancers2 trials
- Chronic lymphocytic leukaemia2 trials
- Diabetic eye disease2 trials
- High blood pressure2 trials
- Macular degeneration2 trials
- Pulmonary arterial hypertension2 trials
- Sarcoma2 trials
- Type 2 diabetes2 trials
- Acute myeloid leukaemia1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- and 12 more
- Phase
- Phase 29 trials
- Phase 38 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting11 trials
- Completed7 trials
- Recruiting6 trials
- Not yet recruiting2 trials
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto5 trials
- Hoffmann-La Roche2 trials
- Abbott Diabetes Care1 trial
- Actelion1 trial
- Alexion Pharmaceuticals, Inc.1 trial
- and 16 more
Running trials
Not yet recruiting
Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma
Recruiting
Searching simple biomarkers to phenotype type 2 diabetic patients and personalize their treatment
Recruiting
PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Active, not recruiting
Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
Recruiting
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Active, not recruiting
Active, not recruiting
Not yet recruiting
Active, not recruiting
Active, not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Recruiting
A Study of Elritercept Alone or Together With Ruxolitinib in Adults With Myelofibrosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Early DOlutegravir/LAmivudine Switching after virological suppression (EDOLAS Study)
Recruiting
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Sarcoma2 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Pompe disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026